Clinical Trial: Lu-177 DOTATOC (PRRT) in adult subjects with Somatostatin receptor (SSTR) positive Pulmonary, Pheochromocytoma, Paraganglioma, Unknown primary, and Thymic Neuroendocrine Tumors September 12, 2020 Read More »
Clinical Trials – ONC201 for Neuroendocrine Cancer (including Pheo/Para) September 9, 2019 Read More »
All you need to know about Peptide Receptor Radionuclide Therapy (PRRT) November 17, 2020 Read More »
Neuroendocrine Tumor Drug Clinical Trial – Cabozantinib (includes news on Pheochromoctyoma and Paraganglioma) November 27, 2020 Read More »
The Syndromes of Neuroendocrine Cancer – Early Signs of a Late Diagnosis November 27, 2020 Read More »
